Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Phillip, Toth"'
Autor:
Domenica M, Rubino, Frank L, Greenway, Usman, Khalid, Patrick M, O'Neil, Julio, Rosenstock, Rasmus, Sørrig, Thomas A, Wadden, Alicja, Wizert, W Timothy, Garvey, Phillip, Toth
Publikováno v:
JAMA
IMPORTANCE: Phase 3 trials have not compared semaglutide and liraglutide, glucagon-like peptide-1 analogues available for weight management. OBJECTIVE: To compare the efficacy and adverse event profiles of once-weekly subcutaneous semaglutide, 2.4 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::14f4c463fa43c8a3e8cfca6212b83cdd
https://pubmed.ncbi.nlm.nih.gov/35500264
https://pubmed.ncbi.nlm.nih.gov/35500264
Publikováno v:
Point of Care: The Journal of Near-Patient Testing & Technology. 1:222-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36c4acc7e32b4992e1dceaf0bb402119
https://doi.org/10.1097/00134384-200209000-00028
https://doi.org/10.1097/00134384-200209000-00028
Publikováno v:
Point of Care: The Journal of Near-Patient Testing & Technology. 1:222-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00358c5d3152b88befe7f18eead02d35
https://doi.org/10.1097/00134384-200209000-00026
https://doi.org/10.1097/00134384-200209000-00026
Autor:
Wayne Hellstrom, Phillip Toth, Sander Shapiro, James W. Overstreet, Daniel Z. Wang, Stuart S. Howards, Carol A. Jacobsen, Keith D. Kaufman, Ronald Lewis, Michael M. Lieber, Tom Shown, Jonathan P. Jarow, Steven Petrou, Jaime Bonilla, Randle S. Corfman, Peter Carroll, Johnny Roy, John Gould, Vivian L. Fuh
Publikováno v:
The Journal of Urology. :1295-1300
Purpose: Finasteride, an oral type 2, 5α-reductase inhibitor, is used in 1 mg. daily doses for the treatment of male pattern hair loss. A dose of 5 mg. finasteride daily reduces ejaculate volume by approximately 25%, and reduces prostate volume by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1822ebe8946b50d1621cc972a238c26e
https://doi.org/10.1097/00005392-199910000-00014
https://doi.org/10.1097/00005392-199910000-00014
Autor:
Jonathon Isaacsohn, Bruce R. Gordon, Phillip Toth, Julie Samuels, Stuart R. Weiss, Peter B. Jones, Maureen A. Dillon, Michael H. Davidson, Steven K. Burke
Publikováno v:
Archives of Internal Medicine. 159:1893
To compare colesevelam hydrochloride (Cholestagel), a nonabsorbed hydrogel with bile acid-sequestering properties, with placebo for its lipid-lowering efficacy, its effects on laboratory and clinical safety parameters, and the incidence of adverse ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3079c61da1be763c8c443260969c0e2
https://doi.org/10.1001/archinte.159.16.1893
https://doi.org/10.1001/archinte.159.16.1893
Publikováno v:
Cellular Immunology. 40:326-335
Suppression of in vitro antibody forming potential of normal cells by leukemic cells of AKR and normal neonatal mice have many similarities. In both cases the suppression is by cell contact rather than by the elaboration of soluble suppressive factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2472dd92e902aa944cf59cab2dfa31d
https://doi.org/10.1016/0008-8749(78)90340-4
https://doi.org/10.1016/0008-8749(78)90340-4